Here, we used 3D imaging to evaluate the expression of pS6, a downstream effector of the PI3K/AKT/mTOR pathway and a tumor marker (13, 14), in intact UTUC samples. Here, MTOR is linked to renal pelvis/ureter urothelial carcinoma.